FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

Source: The Hill News · Bias: Center

Summary

The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same prescription drug that the Trump administration touted from the Oval Office as a potential treatment for symptoms of autism last year. Senior administration officials announced that Wellcovorin,…

Related Coverage

More Headlines From March 10, 2026

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism
The Hill News

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

Center

The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same prescription drug that the Trump administration touted from the Oval Office as a potential treatment for symptoms of autism last year. Senior administration officials announced that Wellcovorin,…